PVG Asset Management’s CalciMedica CALC Stock Holding History

PVG Asset Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45,830	Closed	-$302K	–	129
2025 Q4	$302K	Buy	+45,830	New	+$179K	0.64%	47
2025 Q2	–	Sell	-30,385	Closed	-$58K	–	61
2025 Q1	$58K	Buy	+30,385	New	+$75.7K	0.25%	42
2024 Q4	–	Sell	-15,115	Closed	-$67K	–	53
2024 Q3	$67K	Buy	+15,115	New	+$66.4K	0.27%	41

Other funds holding CALC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PVG Asset Management's CALC Position: Q1 2026 in Review

PVG Asset Management sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 45,830 shares — an estimated $302K sold.

PVG Asset Management first reported a position in CALC in Q3 2024 and held it in 3 quarters. The position peaked at $302K in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

PVG Asset Management reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
PVG Asset Management sold 45,830 CalciMedica shares in Q1 2026, an estimated $302K.
PVG Asset Management first reported a position in CalciMedica in Q3 2024 and held it in 3 quarters.
PVG Asset Management's CalciMedica position peaked at $302K in Q4 2025.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on PVG Asset Management's 13F filing for Q1 2026, filed 16 Jun 2026.